2020
DOI: 10.1002/jhbp.855
|View full text |Cite
|
Sign up to set email alerts
|

Indocyanine green administration a day before surgery may increase bile duct detectability on fluorescence cholangiography during laparoscopic cholecystectomy

Abstract: Background: The optimal indocyanine green (ICG) administration protocol for fluorescence cholangiography during laparoscopic cholecystectomy (LC) has yet to be determined. Methods: A prospective study including 20 cases of ICG fluorescence-navigated LC was conducted. Accordingly, the first 10 patients were administered 2.5 mg of ICG on the day of surgery after intubation (surgery-day group), while the remaining 10 consecutive patients were administered 0.25 mg/kg of ICG on the evening before surgery (one-day-b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
20
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 32 publications
2
20
0
Order By: Relevance
“…The ensuing comments are based on the analysis of 19 studies (6,10-27) documenting the use of ICG NIRC in LCs or RCs, for non-malignant gallbladder disease (symptomatic biliary lithiasis, acute or chronic cholecystitis, and gallbladder polyps) in a total of 2,490 patients. Only 2are randomized controlled studies (RCT), 11 prospective and 6 are retrospective studies (7,(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28) (Table I). The safety of the ICG was excellent, there was only one report of a self-resolved rash (0.04%), with no other adverse reactions.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The ensuing comments are based on the analysis of 19 studies (6,10-27) documenting the use of ICG NIRC in LCs or RCs, for non-malignant gallbladder disease (symptomatic biliary lithiasis, acute or chronic cholecystitis, and gallbladder polyps) in a total of 2,490 patients. Only 2are randomized controlled studies (RCT), 11 prospective and 6 are retrospective studies (7,(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28) (Table I). The safety of the ICG was excellent, there was only one report of a self-resolved rash (0.04%), with no other adverse reactions.…”
Section: Methodsmentioning
confidence: 99%
“…In most of the cases, ICG was administered shortly before or at the induction of anesthesia, with a time range of 30-60 min to the intervention. The doses in these cases were either a fixed dose varying between 1.25-7.5 mg of diluted ICG solution (14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)27), or an adjusted dose of 0.02-0.62 mg/kg (11,12,28). The majority of the studies included in the review used 2.5 mg administered within 1 h before imaging (7,14-23).…”
Section: Dose Timing and Administrationmentioning
confidence: 99%
“…Another debated point is the optimal dosage and timing of administration of ICG to obtain optimal visualization of the extrahepatic biliary tree [ 24 , 25 ]. We adopted a dosage of 0.35 mg/kg in all cases, and the median time of administration was 15.6 h prior to surgery.…”
Section: Discussionmentioning
confidence: 99%
“…For fluorescence cholangiography, original method was 2.5 mg before surgery [16]. In this regard, studies discuss that earlier timing may offer clear contrast between bile duct and background [21,22]. To weaken the fluorescence of bile for the contrast between BDTT and bile, we consider small amount of ICG (2.5 mg) one day before surgery is reasonable.…”
Section: Discussionmentioning
confidence: 99%